Real-World Patterns of First-Line Hydroxyurea Treatment Among Patients with Essential Thrombocythemia in US Community Oncology Practices

被引：0
|
作者：
Yu, Jingbo
Colucci, Philomena
Paranagama, Dilan Chamikara
Sivaraman, Smitha
Atanasov, Pavel
Hanna, Becky
Tang, Jackson
Parasuraman, Shreekant V.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4203
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [41] Real-world treatment patterns of adult multiple myeloma patients treated with carfilzomib in the US community oncology setting.
    Panjabi, Sumeet
    Medhekar, Rohan
    Aguilar, Kathleen
    Wilson, Thomas
    Amirian, E. Susan
    Mezzi, Khalid
    Rifkin, Robert M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [42] First-line systemic real-world treatment of patients with advanced/metastatic NSCLC in the UK
    Wang, M.
    Dhokia, P.
    Menon, S.
    Martindale, B.
    ANNALS OF ONCOLOGY, 2018, 29 : 22 - 22
  • [43] First-Line Treatment Outcomes of CML Patients in a Real-World Data Setting in Lebanon
    Nasr, Fadi
    Yehia, Intissar
    El Khoury, Reem
    Diab, Saada
    Al Ghoche, Ahmad
    Nasr, Lewis
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S332 - S333
  • [44] Real-World Treatment Patterns and Outcomes of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma Treated in US Oncology Practices
    Ge, Wenzhen
    Wu, Ning
    Chen, Chieh-, I
    Inocencio, Timothy J.
    Lafontaine, Patrick R.
    Seebach, Frank
    Fury, Matthew
    Harnett, James
    Ruiz, Emily S.
    CANCER MANAGEMENT AND RESEARCH, 2024, 16 : 841 - 854
  • [45] Real-World Treatment Patterns and Healthcare Resource Utilization in Patients with Waldenstrom Macroglobulinemia Initiating First-Line Treatment with Ibrutinib or Zanubrutinib
    Paludo, Jonas
    Sarosiek, Shayna R.
    von Keudell, Gottfried R.
    Salkar, Monika
    Zhou, Summera
    Kim, Sonia
    Cheng, Ning
    Pacia, Michelle
    Karve, Sudeep
    Castillo, Jorge J.
    BLOOD, 2023, 142
  • [46] Real-World Treatment Patterns and Outcomes Following First-Line Pertuzumab and Trastuzumab Among Patients with HER2+?Metastatic Breast Cancer
    Mehta, Sandhya
    Xie, Jipan
    Ionescu-Ittu, Raluca
    Nie, Xiaoyu
    Kwong, Winghan J.
    ONCOLOGY AND THERAPY, 2023, 11 (04) : 481 - 493
  • [47] Real-World Treatment Patterns and Outcomes Following First-Line Pertuzumab and Trastuzumab Among Patients with HER2+ Metastatic Breast Cancer
    Sandhya Mehta
    Jipan Xie
    Raluca Ionescu-Ittu
    Xiaoyu Nie
    Winghan J. Kwong
    Oncology and Therapy, 2023, 11 : 481 - 493
  • [48] REAL-WORLD TREATMENT PATTERNS AMONG PATIENTS WITH METASTATIC RENAL CELL CARCINOMA RECEIVING FIRST-LINE THERAPY IN THE UNITED STATES VETERAN POPULATION
    Bhanegaonkar, A.
    Kim, R.
    Pandya, S.
    Wang, L.
    Krulewicz, S.
    Pennock, G.
    Phatak, H.
    VALUE IN HEALTH, 2019, 22 : S116 - S116
  • [49] First-line Ibrutinib Treatment is Associated with Longer Time to Next Treatment in a Real-World US Veterans Population
    Huang, Qing
    Ellis, Lorie
    Wang, Li
    Shrestha, Sulena
    Sundaram, Murali
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S285 - S285
  • [50] First-line pembrolizumab monotherapy in metastatic PD-L1 positive non-small cell lung cancer: A real-world analysis of time on treatment in US community oncology practices
    Velcheti, V.
    Chandwani, S.
    Chen, X.
    Pietanza, M. C.
    Burke, T.
    ANNALS OF ONCOLOGY, 2018, 29 : 18 - 18
12345